Healing of segmental bone defects by direct percutaneous gene delivery: Effect of vector dose

Human Gene Therapy

Volumn 18, Issue 10, 2007, Pages 907-915

  Betz, Volker M ^a   Betz, Oliver B ^a   Glatt, Vaida ^b   Gerstenfeld, Louis C ^c   Einhorn, Thomas A ^c   Bouxsein, Mary L ^b   Vrahas, Mark S ^a   Evans, Christopher H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MINERAL; BONE RADIOGRAPHY; BONE REGENERATION; CARTILAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXPRESSION VECTOR; FEMUR; HISTOLOGY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; RAT; SINGLE DRUG DOSE; TRABECULAR BONE; TREATMENT OUTCOME;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; FRACTURE HEALING; FRACTURES, BONE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; RATTUS;

EID: 35348876799     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.077     Document Type: Article

References (43)

1. AROSARENA, O., and COLLINS, W. (2005). Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthod. Craniofac. Res. 8, 267-276.
2. BALTZER, A.W., LATTERMANN, C., WHALEN, J.D., WOOLEY, P., WEISS, K., GRIMM, M., GHIVIZZANI, S.C., ROBBINS, P.D., and EVANS, C.H. (2000). Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther. 7, 734-739.
3. BERTONE, A.L., PITTMAN, D.D., BOUXSEIN, M.L., LI, J., CLANCY, B., and SEEHERMAN, H.J. (2004). Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J. Orthop. Res. 22, 1261-1270.
4. BETZ, O.B., BETZ, V.M., NAZARIAN, A., PILAPIL, C.G., VRAHAS, M.S., BOUXSEIN, M.L., GERSTENFELD, L.C., EINHORN, T.A., and EVANS, C.H. (2006). Direct percutaneous gene delivery to enhance healing of segmental bone defects. J. Bone Joint Surg. Am. 88, 355-365.
5. BODEN, S.D., ZDEBLICK, T.A., SANDHU, H.S., and HEIM, S.E. (2000). The use of rhBMP-2 in interbody fusion cages: Definitive evidence of osteoinduction in humans [a preliminary report]. Spine 25, 376-381.
6. CAO, H., KOEHLER, D.R., and HU, J. (2004). Adenoviral vectors for gene replacement therapy. Viral Immunol. 17, 327-333.
7. CHEN, D., ZHAO, M., and MUNDY, G.R. (2004). Bone morphogenetic proteins. Growth Factors 22, 233-241.
8. COLTERJOHN, N.R., and BEDNAR, D.A. (1997). Procurement of bone graft from the iliac crest: An operative approach with decreased morbidity. J. Bone Joint Surg. Am. 79, 756-759.
9. DRAGOO, J.L., CHOI, J.Y., LIEBERMAN, J.R., HUANG, J., ZUK, P.A., ZHANG, J., HEDRICK, M.H., and BENHAIM, P. (2003). Bone induction by BMP-2 transduced stem cells derived from human fat. J. Orthop. Res. 21, 622-629.
10. EINHORN, T.A. (2003). Clinical applications of recombinant human BMPs: Early experience and future development. J. Bone Joint Surg. Am. 85(Suppl. 3), 82-88.
11. EINHORN, T.A., LANE, J.M., BURSTEIN, A.H., KOPMAN, C.R., and VIGORITA, V.J. (1984). The healing of segmental bone defects induced by demineralized bone matrix: A radiographic and biomechanical study. J. Bone Joint Surg. Am. 66, 274-279.
12. EVANS, C.H., and ROBBINS, P.D. (1995). Possible orthopaedic applications of gene therapy. J. Bone Joint Surg. Am. 77, 1103-1114.
13. EVANS, C.H., GHIVIZZANI, S.C., and ROBBINS, P.D. (2004). The 2003 Nicolas Andry Award: Orthopaedic gene therapy. Clin. Orthop. Relat. Res. 429, 316-329.
14. EVANS, C.H., PALMER, G.D., PASCHER, A., PORTER, R., KWONG, F.N., GOUZE, E., GOUZE, J.N., LIU, F., STEINERT, A., BETZ, O., BETZ, V., VRAHAS, M., and GHIVIZZANI, S.C. (2007). Facilitated endogenous repair: Making tissue engineering simple, practical, and economical. Tissue Eng. 13, 1987-1993.
15. FRIEDLAENDER, G.E., PERRY, C.R., COLE, J.D., COOK, S.D., CIERNY, G., MUSCHLER, G.F., ZYCH, G.A., CALHOUN, J.H., LAFORTE, A.J., and YIN, S. (2001). Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83(Suppl. 1), S151-S158.
16. HARDY, S., KITAMURA, M., HARRIS-STANSIL, T., DAI, Y., and PHIPPS, M.L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71, 1842-1849.
17. HILDEBRAND, T., LAIB, A., MULLER, R., DEQUEKER, J., and RUEGSEGGER, P. (1999). Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J. Bone Miner. Res. 14, 1167-1174.
18. KNESER, U., SCHAEFER, D.J., POLYKANDRIOTIS, E., and HORCH, R.E. (2006). Tissue engineering of bone: The reconstructive surgeon's point of view. J. Cell. Mol. Med. 10, 7-19.
19. KREBSBACH, P.H., GU, K., FRANCESCHI, R.T., and RUTHERFORD, R.B. (2000). Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11, 1201-1210.
20. LEE, J.Y., PENG, H., USAS, A., MUSGRAVE, D., CUMMINS, J., PELINKOVIC, D., JANKOWSKI, R., ZIRAN, B., ROBBINS, P., and HUARD, J. (2002). Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum. Gene Ther. 13, 1201-1211.
21. LI, G., BOUXSEIN, M.L., LUPPEN, C., LI, X.J., WOOD, M., SEEHERMAN, H.J., WOZNEY, J.M., and SIMPSON, H. (2002). Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J. Orthop. Res. 20, 779-788.
22. LIEBERMAN, J.R., LE, L.Q., WU, L., FINERMAN, G.A., BERK, A., WITTE, O.N., and STEVENSON, S. (1998). Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J. Orthop. Res. 16, 330-339.
23. LIEBERMAN, J.R., DALUISKI, A., and EINHORN, T.A. (2002). The role of growth factors in the repair of bone: Biology and clinical applications. J. Bone Joint Surg. Am. 84, 1032-1044.
24. MAKAROV, S.S., OLSEN, J.C., JOHNSTON, W.N., ANDERLE, S.K., BROWN, R.R., BALDWIN, A.S., JR., HASKILL, J.S., and SCHWAB, J.H. (1996). Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. U.S.A. 93, 402-406.
25. MEINEL, L., FAJARDO, R., HOFMANN, S., LANGER, R., CHEN, J., SNYDER, B., VUNJAK-NOVAKOVIC, G., and KAPLAN, D. (2005). Silk implants for the healing of critical size bone defects. Bone 37, 688-698.
26. MONT, M.A., RAGLAND, P.S., BIGGINS, B., FRIEDLAENDER, G., PATEL, T., COOK, S., ETIENNE, G., SHIMMIN, A., KILDEY, R., RUEGER, D.C., and EINHORN, T.A. (2004). Use of bone morphogenetic proteins for musculoskeletal applications: An overview. J. Bone Joint. Surg. Am. 86(Suppl. 2), 41-55.
27. NEMUNAITIS, J., MEYERS, T., SENZER, N., CUNNINGHAM, C., WEST, H., VALLIERES, E., ANTHONY, S., VUKELJA, S., BERMAN, B., TULLY, H., PAPPEN, B., SARMIENTO, S., ARZAGA, R., DUNIHO, S., ENGARDT, S., MEAGHER, M., and CHEEVER, M.A. (2006). Phase I trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer. Mol. Ther. 13, 1185-1191.
28. PALMER, G.D., GOUZE, E., GOUZE, J.N., BETZ, O.B., EVANS, C.H., and GHIVIZZANI, S.C. (2003). Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol. Biol. 215, 235-246.
29. PENG, H., WRIGHT, V., USAS, A., GEARHART, B., SHEN, H.C., CUMMINS, J., and HUARD, J. (2002). Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 110, 751-759.
30. PROPHET, E.B., MILLS, B., ARRINGTON J.B., and SOBIN, L.H. (1992). AFIP Laboratory Methods in Histotechnology (Armed Forces Institute of Pathology, Washington, D.C.).
31. RAJAGOPALAN, S., LU, L., YASZEMSKI, M.J., and ROBB, R.A. (2005). Optimal segmentation of microcomputed tomographic images of porous tissue-engineering scaffolds. J. Biomed. Mater. Res. 75, 877-887.
32. REDDI, A.H. (2001). Bone morphogenetic proteins: From basic science to clinical applications. J. Bone Joint Surg. Am. 83(Suppl. 1), 1-6.
33. SCADUTO, A.A., and LIEBERMAN, J.R. (1999). Gene therapy for osteoinduction. Orthop. Clin. North Am. 30, 625-633.
34. SCHREIBER, R.E., BLEASE, K., AMBROSIO, A., AMBURN, E., SOSNOWSKI, B., and SAMPATH, T.K. (2005). Bone induction by AdBMP-2/collagen implants. J. Bone Joint Surg. Am. 87, 1059-1068.
35. SEEHERMAN, H., LI, R., BOUXSEIN, M., KIM, H., LI, X.J., SMITH-ADALINE, E.A., AIOLOVA, M., and WOZNEY, J.M. (2006). rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J. Bone Joint Surg. Am. 88, 144-160.
36. SHEN, H.C., PENG, H., USAS, A., GEARHART, B., FU, F.H., and HUARD, J. (2004). Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J. Gene Med. 6, 984-991.
37. STOLBERG, S.G. (1999). The biotech death of Jesse Gelsinger. New York Times Magazine, November 28, 1999, pp. 136-140.
38. SUGIYAMA, O., AN, D.S., KUNG, S.P., FEELEY, B.T., GAMRADT, S., LIU, N.Q., CHEN, I.S., and LIEBERMAN, J.R. (2005). Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol. Ther. 11, 390-398.
39. TALWAR, R., DI SILVIO, L., HUGHES, F.J., and KING, G.N. (2001). Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J. Clin. Periodontol. 28, 340-347.
40. ULUDAG, H., GAO, T., PORTER, T.J., FRIESS, W., and WOZNEY, J.M. (2001). Delivery systems for BMPs: factors contributing to protein retention at an application site. J. Bone Joint Surg. Am. 83, 128-135.
41. URIST, M.R. (1965). Bone: Formation by autoinduction. Science 150, 893-899.
42. VERMA, I.M., and SOMIA, N. (1997). Gene therapy: Promises, problems and prospects. Nature 389, 239-242.
43. YEN, N., IOANNIDES, C.G., XU, K., SWISHER, S.G., LAWRENCE, D.D., KEMP, B.L., EL-NAGGAR, A.K., CRISTIANO, R.J., FANG, B., GLISSON, B.S., HONG, W.K., KHURI, F.R., KURIE, J.M., LEE, J.J., LEE, J.S., MERRITT, J.A., MUKHOPADHYAY, T., NESBITT, J.C., NGUYEN, D., PEREZ-SOLER, R., PISTERS, K.M., PUTNAM, J.B., JR., SCHRUMP, D.S., SHIN, D.M., WALSH, G.L., and ROTH, J.A. (2000). Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther. 7, 530-536.